Flow Traders U.S.’s Bellevue Life Sciences Acquisition Corp. Rights BLACR Stock Holding History

Flow Traders U.S.’s Portfolio BLACR Stock Details BLACR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-15,696	Closed	-$2K	–	1420
2024 Q4	$2K	Sell	15,696 -610	-4%	-$76	﹤0.01%	938
2024 Q3	$2K	Buy	16,306 +1,785	+12%	+$237	﹤0.01%	816
2024 Q2	$1K	Buy	14,521 +2,671	+23%	+$365	﹤0.01%	827
2024 Q1	$2K	Sell	11,850 -2,708	-19%	-$414	﹤0.01%	710
2023 Q4	$2K	Buy	+14,558	New	+$2.35K	﹤0.01%	737

Flow Traders U.S.'s BLACR Position: Q1 2025 in Review

Flow Traders U.S. sold out of Bellevue Life Sciences Acquisition Corp. Rights (BLACR) in Q1 2025, closing a stake of 15,696 shares — an estimated $2K sold.

Flow Traders U.S. first reported a position in BLACR in Q4 2023 and held it in 5 quarters. The position peaked at $2K in Q4 2024. 0 funds tracked by Wall St. Rank hold BLACR as of Q1 2025.

Flow Traders U.S. reported no remaining Bellevue Life Sciences Acquisition Corp. Rights position as of Q1 2025 after selling out during the quarter.
Flow Traders U.S. sold 15,696 Bellevue Life Sciences Acquisition Corp. Rights shares in Q1 2025, an estimated $2K.
Flow Traders U.S. first reported a position in Bellevue Life Sciences Acquisition Corp. Rights in Q4 2023 and held it in 5 quarters.
Flow Traders U.S.'s Bellevue Life Sciences Acquisition Corp. Rights position peaked at $2K in Q4 2024.
0 funds tracked by Wall St. Rank held Bellevue Life Sciences Acquisition Corp. Rights as of Q1 2025.

Based on Flow Traders U.S.'s 13F filing for Q1 2025, filed 14 May 2025.